Mainz Biomed Partners with OncoVanguard8 to Bring ColoAlert to South America

Mainz Biomed has signed a Memorandum of Understanding with OncoVanguard8 to introduce ColoAlert, a DNA-based colorectal cancer screening test, to South America, starting with Peru. The test aims to increase screening participation, facilitate timely diagnosis, and align with national public health initiatives to reduce CRC-related mortality. The rollout is expected to raise screening participation and enhance long-term population health outcomes in the three initial launch markets.